152 related articles for article (PubMed ID: 23870804)
1. Development of in vitro assays for measuring the relative potency of leptospiral bacterins containing serogroups canicola, grippotyphosa, icterohaemorrhagiae, and pomona.
Ruby KW; Srinivas GB
Biologicals; 2013 Sep; 41(5):308-14. PubMed ID: 23870804
[TBL] [Abstract][Full Text] [Related]
2. USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.
Srinivas GB; Walker A; Rippke B
Biologicals; 2013 Sep; 41(5):298-302. PubMed ID: 23838570
[TBL] [Abstract][Full Text] [Related]
3. Development of Leptospira in vitro potency assays: EU/industry experience and perspectives.
Klaasen HL; van der Veen M; Molkenboer MJ; Bruderer U
Biologicals; 2013 Sep; 41(5):315-22. PubMed ID: 23867758
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
Walker A; Srinivas GB
Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
[TBL] [Abstract][Full Text] [Related]
5. Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.
Alt DP; Wilson-Welder J
Biologicals; 2013 Sep; 41(5):323-4. PubMed ID: 23838569
[TBL] [Abstract][Full Text] [Related]
6. Successful development and validation of an in vitro replacement assay for Leptospira vaccine potency tests.
Kulpa-Eddy J
Dev Biol (Basel); 2012; 134():101-6. PubMed ID: 22888601
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira (L.) serogroup Icterohaemorrhagiae and L. serogroup Canicola in the United States.
Walker A; Olsen R; Toth M; Srinivas G
Biologicals; 2018 Nov; 56():13-18. PubMed ID: 30126631
[TBL] [Abstract][Full Text] [Related]
8. Assay for measuring relative potency of leptospiral bacterins containing serovar pomona.
Ruby KW; Cardella MA; Knudtson WU
Biologicals; 1992 Dec; 20(4):259-66. PubMed ID: 1305402
[TBL] [Abstract][Full Text] [Related]
9. Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.
Stokes W; Srinivas G; McFarland R; Kulpa-Eddy J; Casey W; Walker A; Draayer H; Sebring R; Brown K; Balks E; Stirling C; Klaasen E; Hill R; Rippke B; Ruby K; Alt D; Mukhopadhyay S; Kojima H; Johnson N; Rinckel L; Doelling V; Jones B
Biologicals; 2013 Sep; 41(5):279-94. PubMed ID: 23890729
[TBL] [Abstract][Full Text] [Related]
10. Development of an in vitro assay for measuring the relative potency of leptospiral bacterins containing serovar canicola and its correlation to the hamster potency assay.
Ruby KW; Walden DM; Wannemuehler MJ
Dev Biol Stand; 1996; 86():341. PubMed ID: 8785981
[No Abstract] [Full Text] [Related]
11. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of serum antibodies against six Leptospira serovars in healthy dogs.
Stokes JE; Kaneene JB; Schall WD; Kruger JM; Miller R; Kaiser L; Bolin CA
J Am Vet Med Assoc; 2007 Jun; 230(11):1657-64. PubMed ID: 17542733
[TBL] [Abstract][Full Text] [Related]
13. Leptospiral vaccines: immunogenicity of protein-free medium cultivated whole cell bacterins in swine.
Bey RF; Johnson RC
Am J Vet Res; 1983 Dec; 44(12):2299-301. PubMed ID: 6660619
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immune response of cattle to leptospiral bacterins.
Tripathy DN; Hanson LE; Mansfield ME
Am J Vet Res; 1976 Jan; 37(1):51-5. PubMed ID: 1247197
[TBL] [Abstract][Full Text] [Related]
15. Development of antibody ELISA specific of Leptospira interrogans serovar Grippotyphosa, Canicola, and Icterohaemorrhagiae to monitor vaccine immunogenicity.
Cariou C; Herbet G; Ripart P; Martin-Cagnon N; Bouvet J; Schneider M; Guiot AL; Cupillard L
Vet Immunol Immunopathol; 2020 Jan; 219():109960. PubMed ID: 31760236
[TBL] [Abstract][Full Text] [Related]
16. Product-specific validation of a serological potency test for release of Leptospira vaccines in the European Union.
Stirling C; Novokova V
Biologicals; 2013 Sep; 41(5):330-1. PubMed ID: 23849308
[TBL] [Abstract][Full Text] [Related]
17. Immunological properties of cellular and whole-culture leptospiral bacterins.
Nazier AA; Ewais MA
J Egypt Public Health Assoc; 1997; 72(3-4):369-77. PubMed ID: 17216994
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the Leptospira serovars bratislava, grippotyphosa, mozdok and pomona in French dogs.
Renaud C; Andrews S; Djelouadji Z; Lecheval S; Corrao-Revol N; Buff S; Demont P; Kodjo A
Vet J; 2013 Apr; 196(1):126-7. PubMed ID: 23141966
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses of cattle vaccinated with leptospiral pentavalent outer envelope and whole culture vaccines.
Bey RF; Johnson RC
Am J Vet Res; 1978 Jul; 39(7):1109-14. PubMed ID: 677529
[TBL] [Abstract][Full Text] [Related]
20. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection.
Klaasen HL; van der Veen M; Sutton D; Molkenboer MJ
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):26-9. PubMed ID: 24054091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
